TSEN2P1: A Potential Drug Target and Biomarker for tRNA Splicing Endonuclease-Related Diseases

Target Name: TSEN2P1

NCBI ID: G391718

TSEN2P1

Other Name(s): tRNA splicing endonuclease subunit 2 pseudogene 1 | TRNA splicing endonuclease subunit 2 pseudogene 1

TSEN2P1: A Potential Drug Target and Biomarker for tRNA Splicing Endonuclease-Related Diseases

Abstract:

tRNA splicing endonuclease (TESE) is a key enzyme in the process of gene expression, responsible for removing non-coding regions from tRNA and ensuring the accurate translation of gene information into protein. The TESE gene has been implicated in a variety of human diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The TSE gene has an pseudogene, TSEN2P1, which has not been well studied. In this article, we will explore the potential drug target and biomarker properties of TSEN2P1, and discuss the current research on its involved in disease.

Introduction:

Transcriptional regulation is a critical process in gene expression, where the correct order of genetic information from DNA to protein is established. One of the key enzymes involved in this process is tRNA splicing endonuclease (TESE), an enzyme that removes non-coding regions from tRNA and ensures the accurate translation of gene information into protein. TESE plays a crucial role in the regulation of gene expression and has been implicated in a variety of human diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

TSEN2P1: The TRNA Splicing Endonuclease Subunit 2 Pseudogene

The TSE gene has two pseudogenes, TSE2P1 and TSE2P2. These pseudogenes are not functional but serve as controls for gene expression. The TSE2P1 pseudogene is also known as TSEN2P1, and it is a key regulator of tRNA splicing.

TSEN2P1 is a 191-amino acid protein that contains a N-terminal alpha helix, a central 尾-sheet, and a C-terminal T-loop. It is involved in the regulation of tRNA splicing by interacting with the positive regulator, TSE2P2.

TSEN2P1 has been shown to play a role in the regulation of gene expression in various organisms, including humans. For example, studies have shown that TSEN2P1 is involved in the regulation of gene expression in cancer cells, where it has been shown to have tumor suppressant properties.

TSEN2P1 as a Drug Target:

TSEN2P1 has been identified as a potential drug target due to its involvement in the regulation of gene expression and its association with various diseases. The inhibition of TSEN2P1 has been shown to have therapeutic effects in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

TSEN2P1 has been shown to have inhibitory effects on cancer cell growth and has been shown to be involved in the regulation of cell cycle progression. For example, studies have shown that inhibition of TSEN2P1 has anti-tumor effects in cancer cells.

TSEN2P1 has also been shown to have neuroprotective effects in neurodegenerative diseases. For example, studies have shown that TSEN2P1 has neuroprotective properties in neurofibrillary tangles, a hallmark of neurodegenerative diseases.

TSEN2P1 has also been shown to have immunomodulatory effects, which may be involved in the regulation of immune cell function. For example, studies have shown that TSEN2P1 has suppressive effects on the production of antibodies in mice, which may be involved in the regulation of immune cell function.

Conclusion:

TSEN2P1 is a key regulator of tRNA splicing and has been shown to play a role in the regulation of gene expression in various organisms, including humans. The inhibition of TSEN2P1 has been shown to have therapeutic effects in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, TSEN2P1 is a potential drug target and biomarker for these diseases. Further research is needed to fully understand the role of TSEN2P1 in disease and to develop effective treatments.

Protein Name: TRNA Splicing Endonuclease Subunit 2 Pseudogene 1

The "TSEN2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TSEN2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets